JPRN-UMIN000036606已完成未知
Multicenter PK PD Study of Immune Checkpoint Inhibitors for Patients Aged 75 or Older with Advanced Non Small Cell Lung Cancer. - Elderly Pembro trial
ational Cancer Center Research Institute Division of Molecular Pharmacology0 个研究点目标入组 100 人开始时间: 2019年4月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have treated with Pembrolizumab 2)Patients who denied to collect sample 3)Patients whose attending doctor consider as inappropriate for this study
研究者
相似试验
招募中
Unknown
Study on PK/PD of immune checkpoint inhibitors according to differential dosage in elderly non-small cell lung cancer patientsJPRN-UMIN000052618ational Cancer Center Hospital, Japan64
进行中（未招募）
1 期
A study of immunotherapy combined with regular treatment for liver cancerPatients with Hepatocellular CarcinomaMedDRA version: 20.0Level: PTClassification code 10073071Term: Hepatocellular carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002767-98-IEniversity College Dublin13
招募中
不适用
Predictive biomarker study of immune checkpoint inhibitors in metastatic head and neck squamous cell carcinomaNeoplasmsKCT0007598ational Cancer Center50
招募中
Unknown
A real-world study of efficacy and safety of Immune check point inhibitors in patients with non-small cell lung cancer harboring driver oncogene excepting EGFRJPRN-UMIN000049022orth East Japan Study Group870
已完成
不适用
Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer other than adenocarcinoma or squamous cell carcinoma: multicenter retrospective observational studyon-small cell lung cancer other than adenocarcinoma or squamous cell carcinomaJPRN-UMIN000037777Hamamatsu University School of Medicine60